Will the development of the DBV-Technologies Viaskin patch enable us to bid goodbye to allergies?

Thanks to one company’s efforts, there may be light at the end of the tunnel for sufferers of a number of allergies:see this page to discover why.

The growth in the incidence of allergies has been noticeable in recent years. Frequently-occuring allergies take in both edible substances e.g. peanuts, and non-edible, e.g. house dust mites.

DBV Technologies andViaskin could well be the names on everybody’s lips if this new technology is as effective as tests suggest.

As the name suggests, this epicutaneous patch is applied to the skin. The crucial parts of the patch revolve around its metal backing (PET titanium), breathable over-adhesive and adhesive crown.

The theory behind the patch is actually quite a simple one. An antigen is sprayed onto the patch using electrospray technology. This creates an even layer of dry antigens.The patch creates a ‘condensation chamber’ with the skin, solubilizing the allergen, enabling it to enter the body’s most tolerogenic antigen presenting cells, the Langerhans cells, beginning the process of ‘desensitizing’ the body to said antigens.

Amongst the different patches being tested is a milk allergy treatment, about which you can find out more at http://www.dbv-technologies.com/en/viaskin-products/Viaskin-milk.